SMMT · Summit Therapeutics Inc. · Debt
$17.55
+0.55 (+3.24%)
At close · Sep 11
Going-concern doubt
— flagged Jul 23, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 23, 2026
Market Cap
$14.00B
Shares
797.75M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
93 filings
93 filers
Visit website
Investor relations